Stocks
CareDx, IncCDNA
NASDAQHealthcareBiotechnology$17.01+3.40%
Specializing in precision diagnostics for transplant patients, this company develops non-invasive solutions to monitor organ health. Its AlloMap and AlloSure tests are widely used in post-transplant care, making it a key player in transplant surveillance. Investors monitor its growth potential in the expanding transplant diagnostics market.
Market Cap: $874.9M52W Range: $10.96 – $21.48
Congressional Interest in CareDx, Inc (CDNA)
2 members of Congress have disclosed 14 trades in CareDx, Inc (CDNA), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
2
Buys
6
Sells
8
Who in Congress Is Trading CDNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2021-03-02 | Tom Malinowski | buy | $15K – $50K |